Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01648348
Brief Title: Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

First Submitted : July 20, 2012
First Submitted that Met QC Criteria : July 20, 2012
First Posted : July 24, 2012 (Estimate)

Results First Submitted : September 21, 2017
Results First Submitted that Met QC Criteria : April 24, 2018
Results First Posted : May 23, 2018

Last Update Submitted that Met QC Criteria : April 24, 2018
Last Update Posted : May 23, 2018